Companies: 10,795·Total market cap: $144.5T

Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

YMABNASDAQHealthcare

$8.61

+$0.02(+0.23%)

Market Cap$391224624

P/E Ratio—

52W High$16.11

52W Low$3.55

Avg Volume905K

Open$8.61

Beta0.53

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Y-mAbs Therapeutics, Inc.（YMAB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · YMAB · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Y-mAbs Therapeutics, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Y-mAbs Therapeutics, Inc.

$8.61+0.23%$391.2M #2

Big Cypress Acquisition Corp.

$8.44-19.23%$425.4M #3

Checkpoint Therapeutics, Inc.

$4.26+0.00%$367.7M #4

Climb Bio, Inc.

$10.77+2.09%$734.3M #5

G1 Therapeutics, Inc.

$7.16+0.14%$377.7M #6

iTeos Therapeutics, Inc.

$10.15+0.20%$448.7M

关于 Y-mAbs Therapeutics, Inc.

CEOMichael Rossi

IPO DateSep 21, 2018

Employees104

CountryUS

Websiteymabs.com

Y-mAbs Therapeutics, Inc. is a biopharmaceutical firm already generating revenue, dedicated to discovering, advancing, and selling innovative antibody-derived therapies specifically designed to combat…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Y-mAbs Therapeutics, Inc.（YMAB）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 21, 2018 在 NASDAQ 上市。截至最近交易日，YMAB 股价为 $8.61，市值约为 $391.2M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Y-mAbs Therapeutics, Inc.（YMAB）股价为 $8.61，在 NASDAQ 上市，52周区间为 $3.55 – $16.11。

YMAB 最新股价YMAB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议